5%-6% growth forecast for global pharma market in 2007, by IMS

6 November 2006

The worldwide pharmaceutical market can expect to see growth of around 5%-6% for 2007, compared with 6%-7% in 2006, as the market continues to rebalance in light of changing dynamics. According to IMS Health's 2007 Pharmaceutical Market Forecast, global pharmaceutical sales will expand to about $665.0-$685.0 billion next year.

"In 2007, the market still will be absorbing changes that have defined a new economic reality, one in which growth is shifting from mature markets to emerging ones; new product adoption is not keeping pace with the loss of patent protection by established products; specialty and niche products are playing a larger role; and regulators, payers and consumers are more carefully weighing the risk/benefit factors of pharmaceuticals," said Murray Aitken, senior vice president, corporate strategy at IMS.

The geographic balance of the pharmaceutical market continues to shift away from the USA toward the world's emerging markets countries, with a per capita Gross National Income of less than $20,000. These countries currently represent 17% of the global market, but will contribute 30% of growth next year. In emerging markets, the availability of health care is expanding, and the need for treatments associated with chronic diseases more typically found in developed countries is rapidly increasing, says IMS.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight